| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |